BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,883,901 | -2.8% | 76,286,000 | 0.0% | 2.06% | -4.4% |
| Q2 2023 | $77,072,118 | -3.7% | 76,286,000 | -0.1% | 2.16% | -2.0% |
| Q1 2023 | $80,060,298 | -3.7% | 76,393,000 | -0.8% | 2.20% | +3.6% |
| Q4 2022 | $83,172,605 | +8.2% | 77,043,000 | 0.0% | 2.12% | +9.2% |
| Q3 2022 | $76,896,000 | +0.1% | 77,043,000 | +0.2% | 1.94% | +4.3% |
| Q2 2022 | $76,828,000 | -0.7% | 76,920,000 | 0.0% | 1.86% | +174.1% |
| Q1 2022 | $77,403,000 | +24.1% | 76,920,000 | +29.3% | 0.68% | +31.3% |
| Q4 2021 | $62,365,000 | +69.9% | 59,503,000 | +63.0% | 0.52% | +49.7% |
| Q3 2021 | $36,713,000 | +48.8% | 36,500,000 | +49.0% | 0.35% | +49.1% |
| Q2 2021 | $24,670,000 | – | 24,500,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |